Status:

UNKNOWN

Intervention Effect of High-Definition Transcranial Alternating Current Stimulation (HD-tACS) on Non-suicidal Self-injury (NSSI)

Lead Sponsor:

Anhui Medical University

Conditions:

Transcranial Alternating Current Stimulation

Non-suicidal Self-injury

Eligibility:

All Genders

12-18 years

Phase:

NA

Brief Summary

To investigate the intervention effect of high-definition transcranial alternating current stimulation (HD-tACS) on patients with Non-suicidal Self-injury (NSSI) and its underlying neural mechanism by...

Detailed Description

Forty patients with Non-suicidal Self-injury (NSSI) diagnosed by DSM-5 were recruited from the Second Affiliated Hospital of Anhui Medical University. All participants underwent a structured interview...

Eligibility Criteria

Inclusion

  • The patients were diagnosed by 2 or more senior clinical psychiatrists, meeting DSM-V criteria, and having 1 or more non-suicidal self-injurious behaviors in the last 6 months.
  • 12-18 years of age.
  • The medicine has not changed in the 4 weeks prior to or after this study, and if it has to be changed, the treatment medication is required to be at a subtherapeutic dosage level.

Exclusion

  • The patient has suicidal ideation or has committed suicidal behavior
  • T1 or T2 weighted phase magnetic resonance images show focal brain lesions
  • patients had neurological disorders such as epilepsy, or serious physical illnesses
  • patients had a history of substance abuse and drug dependence in the last 6 months or use of anticonvulsant drugs in the last 3 months
  • patients had received radial cranial electrical stimulation or magnetic stimulation treatment in the last 3 months or received electroconvulsive therapy in the last 6 months
  • patients had previous significant head trauma or EEG abnormality in the last 1 month
  • body-mounted devices unsuitable for treatment, such as pacemakers, artificial valves, and other metal implants.

Key Trial Info

Start Date :

May 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 30 2024

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06127056

Start Date

May 1 2023

End Date

July 30 2024

Last Update

November 14 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Anhui Medical University

Hefei, Anhui, China